The company has certainly managed to get some good coverage of their XDR TB announcement.Its got heaps of coverage in Bio tech news and medical mags in the USA in particular.
Still odd that the cdc suggest TST for persons with BCG jab.I thought this was QFT main advantage.
Regards,
- Forums
- ASX - By Stock
- important message from cst
The company has certainly managed to get some good coverage of...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)